Simvastatin and uterine fibroids: opportunity for a novel therapeutic option


Like Comment

Volume 110, Issue 7, Pages 1272–1273


Mohamed Ali, B. Pharm., M.Sc., Tia Jackson-Bey, M.D., M.P.H., Ayman Al-Hendy, M.D., Ph.D.


Reflections on "Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production" by Malik et al.

Read the full text here.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.